Subscribe To
Regeneron Applauds Supreme Court’s Unanimous Opinion Striking Down Amgen’s PCSK9 Patent Claims and Supporting Scientific Innovation
Decision ends nearly decade-long patent dispute related to Regeneron-invented Praluent® (alirocumab) TARRYTOWN, N.Y., May 18, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) applauds the United States Supreme Court’s unanimous opinion1 ending a nearly decade-long patent dispute related to the Regeneron-invented PCSK9 inhibitor, Praluent® (alirocumab). The decision affirms the United States Court of Appeals […] The post Regeneron Applauds Supreme Court’s Unanimous Opinion S...
Read More
Content Topics
Regeneron
Applauds
Supreme
Court
Unanimous
Opinion
Court s
Striking
Amgen s
Patent
Claims
Supporting
Scientific
Innovation
Forex
Posted: May 18 2023, 15:45
Author Name: forextv
Views: 081534